WuXi Biologics (Cayman) Inc (WXXWY)
3.60
-0.13
(-3.49%)
USD |
OTCM |
May 17, 15:57
WuXi Biologics Enterprise Value: 6.730B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 6.730B |
| May 16, 2024 | 7.000B |
| May 15, 2024 | 6.938B |
| May 14, 2024 | 6.875B |
| May 13, 2024 | 6.688B |
| May 10, 2024 | 7.479B |
| May 09, 2024 | 6.896B |
| May 08, 2024 | 6.605B |
| May 07, 2024 | 6.771B |
| May 06, 2024 | 6.981B |
| May 03, 2024 | 6.607B |
| May 02, 2024 | 6.981B |
| May 01, 2024 | 6.376B |
| April 30, 2024 | 6.313B |
| April 29, 2024 | 6.575B |
| April 26, 2024 | 6.230B |
| April 25, 2024 | 5.960B |
| April 24, 2024 | 6.001B |
| April 23, 2024 | 6.064B |
| April 22, 2024 | 5.983B |
| April 19, 2024 | 5.882B |
| April 18, 2024 | 6.176B |
| April 17, 2024 | 6.176B |
| April 16, 2024 | 6.057B |
| April 15, 2024 | 6.241B |
| Date | Value |
|---|---|
| April 12, 2024 | 6.428B |
| April 11, 2024 | 6.595B |
| April 10, 2024 | 6.659B |
| April 09, 2024 | 6.826B |
| April 08, 2024 | 6.711B |
| April 05, 2024 | 6.242B |
| April 04, 2024 | 6.704B |
| April 03, 2024 | 6.674B |
| April 02, 2024 | 6.663B |
| April 01, 2024 | 6.685B |
| March 28, 2024 | 6.727B |
| March 27, 2024 | 6.482B |
| March 26, 2024 | 6.398B |
| March 25, 2024 | 6.474B |
| March 22, 2024 | 6.336B |
| March 21, 2024 | 6.586B |
| March 20, 2024 | 6.634B |
| March 19, 2024 | 6.545B |
| March 18, 2024 | 6.753B |
| March 15, 2024 | 6.795B |
| March 14, 2024 | 7.589B |
| March 13, 2024 | 9.050B |
| March 12, 2024 | 8.904B |
| March 11, 2024 | 8.570B |
| March 08, 2024 | 8.497B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.882B
Minimum
Apr 19 2024
88.18B
Maximum
Nov 20 2020
31.03B
Average
26.18B
Median
Jul 21 2020
Enterprise Value Benchmarks
| Wuxi AppTec Co Ltd | 13.50B |
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 32.35M |
| Zai Lab Ltd | 1.313B |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Earnings Yield | 6.05% |
| Operating Earnings Yield | 8.02% |
| Normalized Earnings Yield | 6.338 |